Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Radiotherapy”

652 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 652 results

Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Large-scale testing (Phase 3)UnknownNCT00002987
What this trial is testing

Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease

Who this might be right for
Lymphoma
Medical Research Council 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04864067
What this trial is testing

No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Servicio de Salud Metropolitano Sur Oriente 73
Testing effectiveness (Phase 2)Looking for participantsNCT07213934
What this trial is testing

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerRecurrent Head and Neck Squamous Cell Carcinoma
University of Cincinnati 40
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231575
What this trial is testing

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Who this might be right for
Neoadjuvant ImmunotherapyNSCLCChemo-free Therapy
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06014944
What this trial is testing

Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody

Who this might be right for
Rectal Cancer
Changhai Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05798845
What this trial is testing

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Chest Hospital 124
Large-scale testing (Phase 3)Looking for participantsNCT05055648
What this trial is testing

PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy

Who this might be right for
Esophageal CancerRadiotherapySide Effect+1 more
University of Aarhus 396
Not applicableUnknownNCT04116125
What this trial is testing

Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial

Who this might be right for
Breast Neoplasm FemaleLymphatic Metastasis
Kyungpook National University Chilgok Hospital 1,380
Testing effectiveness (Phase 2)Study completedNCT00600587
What this trial is testing

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Guangdong Provincial People's Hospital 24
Testing effectiveness (Phase 2)Ended earlyNCT00889187
What this trial is testing

Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297030
What this trial is testing

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

Who this might be right for
Rectal Cancer
Sun Yat-sen University 37
Not applicableLooking for participantsNCT03731130
What this trial is testing

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant Radiation or Chemoradiation Followed by Surgery in Patients With Rectal Cancer

Who this might be right for
Rectal CancerQuality of LifeRadiation Therapy+1 more
Ludwig-Maximilians - University of Munich 100
Early research (Phase 1)Study completedNCT03279237
What this trial is testing

A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Who this might be right for
GastroEsophageal Cancer
Massachusetts General Hospital 25
Early research (Phase 1)Ended earlyNCT02043860
What this trial is testing

Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Illinois at Chicago 3
Not applicableLooking for participantsNCT04564482
What this trial is testing

PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer

Who this might be right for
Rectal Cancer StageOesophageal Cancer
Johannes Laengle, MD, PhD 20
Early research (Phase 1)Looking for participantsNCT05412082
What this trial is testing

SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
University of Miami 25
Testing effectiveness (Phase 2)Study completedNCT03064490
What this trial is testing

Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)

Who this might be right for
Locally Advanced Esophageal and Gastric Cancers (EGC)
Duke University 35
Testing effectiveness (Phase 2)Looking for participantsNCT06114225
What this trial is testing

Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial

Who this might be right for
Osteosarcoma
Ruijin Hospital 43
Load More Results